펜실베이니아의 암 (전체) 임상 시험
암 (전체) 관련 연구 100개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.
펜실베이니아의 도시
공식 연구 텍스트(영어)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Alliance Cancer Specialists - Media, Media
- Guthrie Medical Group, Sayre
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05920356Childhood Cancer Predisposition Study (CCPS)
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04511806RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Pennsylvania, Philadelphia
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Saint Luke's Cancer Center - Allentown, Allentown
- Saint Luke's University Hospital-Bethlehem Campus, Bethlehem
- 외 21개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Allegheny Health Network, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07195591Pan Tumor Rollover Study
- Lancaster General Health, Lancaster
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT03899155Facial Expression Awareness Training to Understand and Recognize Emotions
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중
6세 ~ 13세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07923370Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Lehigh Valley Health Network, Allentown
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Allegheny General Hospital (AGH)-Allegheny Singer Research Institute, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06901531A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- University of Pennsylvania, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06150157Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
- IRMC Cancer Center, Indiana
- 외 6개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07059884A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Alliance Cancer Specialists, PC, Horsham
- Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
- UPMC Cancer Centers, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06311578Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University - Clinical Research Institute, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- 외 1개
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT03435796Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
- Fox Chase Cancer Center, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06959706A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Children's Hospital of Philadelphia (CHOP) ( Site 4021), Philadelphia
피험자 모집 중1/2상
1 Month – 17 Years · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07630974Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중2상
1세 ~ 26세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07680439Collection of Tissue Samples for Cancer Research
- University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중관찰 연구
2 Months · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT00900198Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- Children's Hospital of Philadelphia, Philadelphia
피험자 모집 중2상
2세 ~ 99세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05783323Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100), Philadelphia
- UPMC Hillman Cancer Center ( Site 0101), Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07405164Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06162221Galleri® in the Medicare Population.
- Geisinger Bloomsburg Hospital - Bloomsburg, Bloomsburg
- FCCC - East Norriton, East Norriton
- FCCC - Buckingham, Furlong
- 외 7개
피험자 모집 중건강한 지원자 환영
50세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT05673018A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- University of Pennsylvania-Perelman Center for Advanced Medicine, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07725796A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT05123482A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275407, Philadelphia
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07023289FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05919264CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- UPMC Hilman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT03328078A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Children's Hospital of Philadelphia (CHOP) ( Site 3021), Philadelphia
피험자 모집 중1/2상
1 Month – 17 Years · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT06941272Autoimmunity After Checkpoint Blockade
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT04119713Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
- Allegheny General Hospital, Pittsburgh
피험자 모집 중관찰 연구
20세 ~ 89세 · 여성 · 2026. 9. 30. 업데이트됨 · NCT07023887A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
- AHN Allegheny General Hospital, Pittsburgh
- Allegheny General Hospital, Pittsburgh
피험자 모집 중
20세 ~ 89세 · 여성 · 2026. 9. 30. 업데이트됨 · NCT07698314A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07192471EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
- AHN Allegheny General Hospital, Pittsburgh
- AHN Allegheny General Hospital, Pittsburgh
피험자 모집 중
20세 ~ 89세 · 여성 · 2026. 9. 28. 업데이트됨 · NCT07704476A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- GSK Investigational Site, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07277270First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
- GSK Investigational Site, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07438782A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- St. Lukes University Hospital /ID# 280204, Bethlehem
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Lehigh Valley Hospital - Cedar Crest, Allentown
- Lehigh Valley Hospital- Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- 외 2개
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Allegheny Health Network, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- Geisinger Medical Center-Cancer Center Hazleton, Hazleton
- 외 4개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06756607A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Fox Chase Cancer Center, Philadelphia
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06634589ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.